Immunovant Inc. Common Stock vs iShares US Aerospace & Defense ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.42 (market cap $6.25B), while iShares US Aerospace & Defense ETF trades at $206.27 (market cap $11.87B). The key difference: iShares US Aerospace & Defense ETF is the larger of the two by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and iShares US Aerospace & Defense ETF for 19 Days on average.
| IMVT | ITA | |
|---|---|---|
Market Cap | $6.25B | $11.87B |
Volume | 1,755,411 | 1,060,125 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $253.22 |
52-Week Low | $17.03 | $198.23 |
Typical Hold Time | 1 Days | 19 Days |
Enterprise Value | $5.35B | — |
Trailing returns across standard periods
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →